Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Treatment of Leprosy

Springer Science and Business Media LLC. Nature. 1932; 130 (3276) : 234-234.
Download PDF
Publication

Lucio Phenomenon: An Unusual Case of Skin Necrosis.

Rusia K, Saoji V, Madke B, et al. Case reports in dermatology. 2024; 16 (1) : 47-54.
Download PDF
Publication

Casos de Hanseníase Notificados em Menores de 15 Anos em Bacabal-MA

Sousa T. J. S, Andrade R. H. L, da Silva M. B. P, et al. Inova Saúde. 2024; 14 (4) : 71-88.
Download PDF
Publication

Educational Approach of Leprosy in Primary School Students: An Approach to Social Stigma Reduction

Menaldi S. L. S. W, Menaldi A. The International Academic Forum. 2024;
Download PDF
Publication

Erythema nodosum leprosum (Type 2 Reaction) in a Patient with Hansen's Disease from a Tertiary care hospital in Jharkhand: A case report

Kumar H, Kumar S, Kumar Mahato S, et al. Biomed Pharmacol J. 2024;
Download PDF
Publication

Changes in neural control in leprosy after high medication on cardiac autonomic modulation

Ferraz D. R. A. F, Vasconcelos R. T., de Melo N. F. B, et al. International Journal of Sciences. 2022; 3 (2) : 119-125.
Download PDF
Publication

Fatores que dificultam o diagnóstico da hanseníase nas perspectivas dos profissionais da saúde da estratégia da saúde da família em unidades básicas de saúde em Imperatriz - MA

Wanderley DDSP, Cruz LFCD, Martins HSDS, et al. Universidade Federal de Juiz de Fora. Revista de APS. 2024;
Download PDF
Publication

Aspectos epidemiológicos da hanseníase no município de Serra Talhada – Pernambuco, 2018 a 2022

Muniz JT, Beserra RSS, Bezerra YBDS, et al. South Florida Publishing LLC. Brazilian Journal of Health Review. 2024; 7 (1) : 5186-5197.
Download PDF
Publication

Leprosy treatment abandonment rate and associated factors in Mato Grosso

Triches A, Auzani MEDO, Calmon MFBF, et al. South Florida Publishing LLC. Revista Foco. 2024; 17 (2) : 1-11.
Download PDF
Publication

Leprosy and health vulnerability in Belo Horizonte, Minas Gerais

Rodrigues RN, Niitsuma ENA, Bueno IDC, et al. Universidade Federal de Minas Gerais - Pro-Reitoria de Pesquisa. REME: Revista Mineira de Enfermagem. 2017;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 124
  • Next page ››
Subscribe to Leprosy (Hansen disease)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD